Nine Masts Capital »

Sangamo Biosciences shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Sangamo Biosciences (SGMO) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Sangamo Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Sangamo Biosciences held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sangamo Biosciences by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 114k 0.25

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Sangamo Biosciences

Armistice Capital
Vanguard Capital Management
Vanguard Group
Renaissance Technologies
Two Sigma Investments
Balyasny Asset Management
Geode Capital Management
BlackRock
Susquehanna International
UBS Group
Vanguard Fiduciary Trust
Jacobs Levy Equity Management
Bank of America Corporation
Charles Schwab Investment Management
Luminus Management

View all funds holding Sangamo Biosciences